SCHEMBL8561282

SCHEMBL8561282

CCCC(=O)c1cc(-c2ccc(F)cc2)c(OC)cc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.52
ALOX15 P16050 3/20 0.48
HSD17B10 Q99714 3/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
RECQL P46063 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
LTB4R Q15722 4/20 0.45
LTB4R2 Q9NPC1 4/20 0.45
FASN P49327 1/20 0.45
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42
TUBB4B P68371 1/20 0.42
TUBB3 Q13509 1/20 0.42
TUBB2A Q13885 1/20 0.42
TUBB8 Q3ZCM7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8562060 0.82 HTT (0.58) HMGCRALDH1A1HPGDLTB4RLTB4R2
SCHEMBL8565876 0.81 LTB4R (0.43) LTB4RLTB4R2NPC1RAB9ASMN1; SMN2
SCHEMBL18909755 0.75 HMGCR (0.45) HMGCRFASNNPC1RAB9ALMNA
SCHEMBL22840673 0.74 HPGD (0.68) HMGCRALOX15HSD17B10ALDH1A1HPGD
SCHEMBL8567276 0.74 SLC6A4 (0.45) ALDH1A1HPGDTUBB4ATUBBTUBA3C
SCHEMBL25742812 0.73 HSD17B10 (0.59) ALOX15HSD17B10ALDH1A1HPGDTSHR
SCHEMBL8567309 0.72 FYN (0.43) ALOX15TDP1LTB4RLTB4R2TUBB4A
SCHEMBL11994151 0.72 SLC6A4 (0.58) HPGDLTB4R2TUBB4ATUBBTUBA3C
SCHEMBL16488700 0.72 HMGCR (0.54) HMGCRALOX15HSD17B10ALDH1A1HPGD
SCHEMBL19602918 0.70 MAPT (0.75) HMGCRALOX15HSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0544488-B1 Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1998-03-11 EP disclosed
WO-1996036347-A1 USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-11-21 WO disclosed
EP-0743064-A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease ELI LILLY AND COMPANY (US) 1996-11-20 EP disclosed
US-5462954-A Antiinflammatory, antiallergens; treating asthma ELI LILLY AND COMPANY (US) 1995-10-31 US disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 EP disclosed